Trial Profile

The Effects of Eicosapentaenoic Acid (EPA) on Biomarkers of Growth and Vascularity in Human Colorectal Cancer Liver Metastases (The EPA for Metastasis Trial)

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 08 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Eicosapentaenoic acid (Primary)
Indications Colorectal cancer
Focus Biomarker; Pharmacodynamics
Acronyms EMT

Most Recent Events

24 Oct 2012 Safety and biomarker results presented at the 20th United European Gastroenterology Week.
31 May 2012 Planned end date changed from 31 Jul 2011 to 1 Aug 2011 as reported by United Kingdom Clinical Research Network record.
05 Aug 2011 United Kingdom Clinical Research Network reports accrual date changed from 93% to 100%.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com